These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19001820)

  • 1. Non-HLA antibodies post-transplantation: clinical relevance and treatment in solid organ transplantation.
    Dragun D; Hegner B
    Contrib Nephrol; 2009; 162():129-39. PubMed ID: 19001820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral responses directed against non-human leukocyte antigens in solid-organ transplantation.
    Dragun D
    Transplantation; 2008 Oct; 86(8):1019-25. PubMed ID: 18946337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of MICA and other non-HLA antibodies in clinical transplantation.
    Sumitran-Holgersson S
    Curr Opin Immunol; 2008 Oct; 20(5):607-13. PubMed ID: 18675346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation.
    Carter V; Shenton BK; Jaques B; Turner D; Talbot D; Gupta A; Chapman CE; Matthews CJ; Cavanagh G
    Transplant Proc; 2005 Mar; 37(2):654-7. PubMed ID: 15848491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-HLA-antibodies targeting Angiotensin type 1 receptor and antibody mediated rejection.
    Dragun D; Catar R; Kusch A; Heidecke H; Philippe A
    Hum Immunol; 2012 Dec; 73(12):1282-6. PubMed ID: 22819838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging issue of MICA antibodies: antibodies to MICA and other antigens of endothelial cells.
    Stastny P; Zou Y; Fan Y; Qin Z; Lavingia B
    Contrib Nephrol; 2009; 162():99-106. PubMed ID: 19001817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
    Dragun D; Catar R; Philippe A
    Kidney Int; 2016 Aug; 90(2):280-288. PubMed ID: 27188505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-HLA antibodies in solid organ transplantation: recent concepts and clinical relevance.
    Dragun D; Catar R; Philippe A
    Curr Opin Organ Transplant; 2013 Aug; 18(4):430-5. PubMed ID: 23838648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological function of the endothelial cell within the setting of organ transplantation.
    Taflin C; Charron D; Glotz D; Mooney N
    Immunol Lett; 2011 Sep; 139(1-2):1-6. PubMed ID: 21641935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies.
    Amico P; Hönger G; Bielmann D; Lutz D; Garzoni D; Steiger J; Mihatsch MJ; Dragun D; Schaub S
    Transplantation; 2008 Jun; 85(11):1557-63. PubMed ID: 18551059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cells as targets of allograft rejection.
    Glotz D; Lucchiari N; Pegaz-Fiornet B; Suberbielle-Boissel C
    Transplantation; 2006 Jul; 82(1 Suppl):S19-21. PubMed ID: 16829788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-major histocompatibility complex class I-related chain A antibodies in organ transplantation.
    Morales-Buenrostro LE; Alberú J
    Transplant Rev (Orlando); 2008 Jan; 22(1):27-38. PubMed ID: 18631856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "antibodyome": or, how to find antibodies?
    Mohebbi N; Wagner CA
    J Nephrol; 2009; 22(4):439-41. PubMed ID: 19662597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of non-HLA antibodies in organ transplantation.
    Dragun D; Philippe A; Catar R
    Curr Opin Organ Transplant; 2012 Aug; 17(4):440-5. PubMed ID: 22790079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novelties in diagnostics and therapy of antibody mediated rejection.
    Dragun D; Rudolph B
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii50-viii53. PubMed ID: 17890264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the presence of anti-HLA antibodies with acute rejection and chronic allograft nephropathy in the first year after kidney transplantation.
    Toresan R; Manfro RC; Proença MC; Veronese FJ; Salim PH; da Silva DM; Ribeiro AR; Edelweiss MI; Pegas KL; Jobim LF
    Transplant Proc; 2008 Apr; 40(3):718-9. PubMed ID: 18454996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and clinical relevance of antibodies after transplantation.
    Smith JD; Rose M
    Methods Mol Biol; 2006; 333():227-46. PubMed ID: 16790854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-mediated rejection: treatment alternatives and outcomes.
    Singh N; Pirsch J; Samaniego M
    Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HLA system in blood transfusion.
    Navarrete CV
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):511-32. PubMed ID: 11102274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.